HOME >> BIOLOGY >> NEWS
Leading drug discovery and biotechnology scientists and experts discuss latest advancements

Meeting to take place April 15-19, 2007 in Montreal, Canada. Guest Speakers and Topics include:

Eugene Butcher, M.D., professor of pathology, Stanford University School of Medicine, Stanford, Calif., will address how the biology of human cell systems further innovation and drug discovery. The focus of recent pharmaceutical discovery on drug targets instead of drug biology has led to a decline in innovation and in the success rate of investigational drugs. Dr. Butcher describes a broadly applicable approach to evaluating lead compounds and drugs, using panels of human disease models in which primary human cells of multiple types are cultured in complex conditions to mimic disease biology. The effects of a drug in these models provide a unique and clinically informative measure of its usefulness and effectiveness. Dr. Butcher says this process can reduce costs and increase rates at which new drugs are discovered.

Larry Gold, Ph.D., chief executive officer, SomaLogic, Inc., Boulder, Colo., will address ways in which molecular diagnostics can improve health and lower health care costs. Molecular diagnostics, an evolving scientific field, involves the investigation of genes and their protein levels. Through molecular diagnostics, scientists hope to more accurately diagnose certain health conditions and diseases by assessing a genes protein level in patients. Dr. Gold will discuss how this field can reduce overall health care costs by enabling physicians to diagnose diseases or potential health conditions early on, rather than when the patient requires more intensive treatment.

Mel Reichman, Ph.D., Lankenau Institute for Medical Research in Wynnewood, Penn., and Christopher Lipinski, Ph.D., Melior Discovery Waterford, Conn., will debate the benefits and drawbacks recently established National Institutes of Health Roadmap for Medical Research in the 21st Century. Comprised of 10 academic institutions, the NIH Roadmap was created to
'"/>

Contact: Ivette Morello
imorello@environics-usa.com
203-325-8772 x24
Society for Biomolecular Sciences
21-Mar-2007


Page: 1 2

Related biology news :

1. Leading the fight against food poisoning
2. Leading researchers honored for progress in cancer prevention, detection and treatment
3. Leading cause of US food-borne illness makes its own pathway through cells
4. Leading scientists elected to EMBO ranks
5. Leading scientists gather to discuss developments in infectious disease research
6. Leading stem cell expert moves to UK
7. Leading breast cancer researcher awarded new lectureship
8. Leading experts confront global burden of chronic disease 8 Dec. at Abelson Science Seminar
9. Leading researchers from Israel and Southern California to present stem cell symposium
10. Leading experts present latest in cancer prevention research
11. Leading lampreys to slaughter: Pheromone for scourge of Great Lakes identified

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/12/2020)... ... August 12, 2020 , ... Mosio recently announced its ... public health agencies of all sizes. With a focus on tracking symptoms and ... appropriate health care, Mosio helps public health departments automate communications and provide more ...
(Date:7/31/2020)... , ... July 30, 2020 , ... ... (SBIR) Phase II contract awarded by the Joint Science & Technology Office—Chemical and ... project is to develop, optimize, and scale-up a highly efficient mammalian cell culture-based ...
(Date:7/10/2020)... CHURCH, Va. (PRWEB) , ... July 08, 2020 ... ... The Latest on Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July ... may need a comparability study, but what is the most effective way to ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... After research model surgery ... of a great surgery is only the beginning of a successful study, while protecting ... , Join Brad Gien, Global Head of Surgery from Envigo in a ...
(Date:7/10/2020)... ... July 09, 2020 , ... PathSensors ... (MIT) has expanded the company’s exclusive license to include clinical applications for ... diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast and ...
(Date:7/1/2020)... ... June 29, 2020 , ... MedShift , a ... 2020, despite many obstacles created as a result of COVID-19. As a provider ... partnered medical practices and medical manufacturers by expanding access to device offerings, technology ...
(Date:6/28/2020)... ... June 25, 2020 , ... Lumeda Inc. (“Lumeda”), ... announced the company has entered a license agreement with Roswell Park Comprehensive Cancer ... exclusive rights to Roswell Park intellectual property surrounding a novel medical device and ...
Breaking Biology Technology:
Cached News: